LytPhage, Inc.
Biotechnology - Malvern, Pennsylvania, United States
LytPhage, Inc. Employees
LytPhage, Inc. Details
LytPhage is developing novel antibiotic products that harness modified bacterial viruses (phage). They are an attractive alternative to synthetic and fermentation derived antimicrobials because phage can infect and kill only bacterial cells (and not mammalian cells). Early clinical evaluations of phage produced mixed results, but they are receiving attention again due to the increasing need for new pathogen control strategies, and due to recent advances in microbiology and gene manipulation that allow more effective phage to be developed. The technology can be applied to a long list urgent clinical problem like resistant staph, pseudomonas, C. difficile, tuberculosis, and others.
